Christopher D. Payne, Director at Hims & Hers Health, Inc. (HIMS), bought 220,000 shares at $17.74 ($3.9M) on 2024-05-21, disclosed to the SEC on 2024-05-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.74 | 110,000 | $2.0M | 50.0% |
| 2 | $17.74 | 110,000 | $2.0M | 50.0% |
| Total | $17.74 avg | 220,000 | $3.9M | 100% |
| Filing → |
| DASH | SELL | 2023-02-23 | $3.4M | — | Filing → |
| DASH | SELL | 2023-02-13 | $6.0M | — | Filing → |
| DASH | SELL | 2023-01-11 | $3.6M | — | Filing → |